Shares of Hims & Hers are moving higher after President-elect Donald Trump nominated Dr. Marty Makary, a pancreatic surgeon at Johns ...

Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the company is poised to be a ...

After going short the stock in June based on Hunterbrook Media’s reporting, Hunterbrook Capital said today it is long Hims & Hers Health.

Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald ...

Maryland scholars on Monday alternately described President-elect Donald Trump’s pick to lead the U.S. Food and Drug ...

The nominee, a surgeon at Johns Hopkins, has criticized the use of pesticides on food and the industry turning against ...

Shares of Hims & Hers Health, Inc. (NYSE: HIMS) traded higher on Monday in response to President-elect Donald Trump's plans ...

(NEW YORK) — President Donald Trump said he wants Marty Makary, a Johns Hopkins surgeon and author who argued against pandemic lockdowns, to lead the U.S. Food and Drug Administration.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window President-elect Donald Trump has chosen Marty Makary, MD, MPH, to run the FDA. Makary served as the editor-in-chief of ...

President-elect Donald Trump on Friday nominated Dr. Marty Makary to lead the Food and Drug Administration, selecting a surgeon and author who gained national attention for opposing vaccine ...

Makary, a professor at Johns Hopkins University, is the latest in a string of Trump nominees who have declared the U.S. health system “broken," vowing a shakeup. As part of a flurry of ...

President-elect Donald Trump nominated Dr. Marty Makary Friday to lead the Food and Drug Administration, selecting a surgeon and author who opposed vaccine mandates and some other public health ...